Nakafero, G, Grainge, M, Myles, P, Mallen, CD, Zhang, W, Doherty, M, Nguyen-Van-Tam, J and Abhishek, A (2018) Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study. Rheumatology, 57 (10). pp. 1726-1734. ISSN 1462-0332

[thumbnail of C Mallen - Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK.pdf]
Preview
Text
C Mallen - Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK.pdf - Accepted Version

Download (2MB) | Preview

Abstract

Objectives
To examine temporal trend in uptake of seasonal influenza vaccine (SIV) in the UK and explore disease and demographic factors associated with vaccination.

Methods
From the Clinical Practice Research Datalink, 32 751 people with auto-immune rheumatic diseases prescribed DMARDs between 2006 and 2016 were identified. The proportion vaccinated between 1 September of one year and 31 March of the next year was calculated and stratified by age, other indications for vaccination, auto-immune rheumatic diseases type and number of DMARDs prescribed. Stata and Joinpoint regression programs were used.

Results
SIV uptake was high in those aged ⩾65 years (82.3 and 80.7% in 2006–07 and 2015–16, respectively). It was significantly lower in other age groups, but improved over time with 51.9 and 61.9% in the 45–64 year age group, and 32.3 and 50.1% in the <45 year age group being vaccinated in 2006–07 and 2015–16, respectively. While 64.9% of the vaccinations in those ⩾65 years old occurred by 3 November, in time to mount a protective immune response before the influenza activity becomes substantial in the UK, only 38.9% in the 45–64 year and 26.2% in the <45 year age group without any other reason for vaccination received SIV by this date. Women, those with additional indications for vaccination, on multiple DMARDs and with SLE were more likely to be vaccinated.

Conclusion
SIV uptake is low in the under 65s, and the majority of them are not vaccinated in time. Additional effort is required to promote timely uptake of SIV in this population.

Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via OUP at https://doi.org/10.1093/rheumatology/key156 Please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: rheumatoid arthritis, influenza, vaccination, disease modifying anti-rheumatic drugs
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine > RC925 Diseases of the musculoskeletal system
Divisions: Faculty of Medicine and Health Sciences > Primary Care Health Sciences
Depositing User: Symplectic
Date Deposited: 26 Apr 2018 10:09
Last Modified: 23 Apr 2019 01:30
URI: https://eprints.keele.ac.uk/id/eprint/4789

Actions (login required)

View Item
View Item